Michael Poltash

Michael Poltash holds a PhD from Texas A&M University and completed postdoctoral training at Thermo Fisher Scientific. He is responsible for deploying innovative mass spectrometry methods to characterize and elucidate complex phenomena in the discovery and development of biotherapeutics. He is currently a principal scientist in the Cell Engineering & Analytical Sciences group at Johnson & Johnson Innovative Medicine.